Programmed cell death 1 inhibitor alone or combined with chemotherapy for patients with locally advanced or metastatic urothelial carcinoma: a single-center experience
This study suggested that patients with locally advanced or metastatic UC could benefit from PD-1 inhibitor alone or combined with chemotherapy in daily clinical practice. ECOG PS and NLR can be used for prognostication of survival.
Authors
- Peng Zhang (ORCID: https://orcid.org/0009-0002-5909-8770)
- Lei Wang (ORCID: https://orcid.org/0000-0001-8975-0489)
- Xing Huang (ORCID: https://orcid.org/0000-0002-6055-5089)
- Chunyan Sun
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1186/s12894-024-01674-7
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Massachusetts General Hospital